Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, their preparation, compositions containing them and their use as inhibitors of protein kinases.

  • Barberis C
  • Carry J
  • Doerflinger G
  • et al.
N/ACitations
Citations of this article
2Readers
Mendeley users who have this article in their library.

Abstract

Title compds. I [R1 = independently NHCOR2, NHCONHR2, NHCOOR2; R2 = H, (un)substituted cyclo/alkyl, hetero/aryl, etc.; R3-R5 = independently H, (un)substituted alkyl, alkyl/aryl, alkyl/heteroaryl; or NR3R4 = (un)substituted heterocyclyl; etc.] were prepd. as inhibitors of protein kinases, particularly Aurora 2 kinase (data) for treating cancer (no data). E.g., a 7-step synthesis starting from 3,4,5-tribromopyrazole was given for thienopyrazole II. II inhibited Aurora 1, Aurora 2, CDK2 and Tie2 with IC50 of 8 nM, 8 nM, 177 nM, and 117 nM, resp. I are useful for treating neoplasm, psoriasis, glaucoma, leukemias, inflammations, etc. [on SciFinder(R)]

Cite

CITATION STYLE

APA

Barberis, C., Carry, J.-C., Doerflinger, G., Barbalat-Damour, D., Clerc, F.-F., & Minoux, Herve. (2006, September 8). Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, their preparation, compositions containing them and their use as inhibitors of protein kinases. PCT Int. Appl. Aventis Pharma S.A., Fr. .

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free